Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cutler

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
International Journal of STD & AIDS|December 20, 2013
The aetiology of vaginal symptoms in rural HaitiClaire C Bristow, Tania Desgrottes, Lauren Cutler, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 26, 2019
A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects
Vikas Kumar Dawra, Yali Liang, Haihong Shi, et al.
Journal of Hepatology|June 20, 2006
A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)Marcelo Silva, Jorge Poo, Frank Wagner, et al.
The American Journal of Managed Care|October 23, 2009
Bending the curve: effective steps to address long-term healthcare spending growthJoseph Antos, John Bertko, Michael Chernew, et al.
Journal of Survey Statistics and Methodology|August 2, 2021
COMBINING INFORMATION FROM MULTIPLE DATA SOURCES TO ASSESS POPULATION HEALTHTrivellore Raghunathan, Kaushik Ghosh, Allison Rosen, et al.
Health Services Research|March 19, 2026
National Trends in Market Competition for Hospital-Based Pediatric Services: 2011-2018Olivia Zhao, Carolyn San Soucie, Daniel A Rauch, et al.
Health Services Research|July 18, 2023
Specialist use among privately insured children with disabilitiesAlyna T Chien, Lauren E Wisk, Nancy Beaulieu, et al.
Critical Care Medicine|February 9, 2005
Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular responseAnand Kumar, Sergio Zanotti, Gene Bunnell, et al.
The American Journal of Managed Care|February 26, 2011
Bending the curve through health reform implementationJoseph Antos, John Bertko, Michael Chernew, et al.
Gastroenterology|April 6, 2007
SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonrespondersChristoph Sarrazin, Regine Rouzier, Frank Wagner, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
International Journal of STD & AIDS|December 20, 2013
The aetiology of vaginal symptoms in rural HaitiClaire C Bristow, Tania Desgrottes, Lauren Cutler, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 26, 2019
A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects
Vikas Kumar Dawra, Yali Liang, Haihong Shi, et al.
Journal of Hepatology|June 20, 2006
A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)Marcelo Silva, Jorge Poo, Frank Wagner, et al.
The American Journal of Managed Care|October 23, 2009
Bending the curve: effective steps to address long-term healthcare spending growthJoseph Antos, John Bertko, Michael Chernew, et al.
Journal of Survey Statistics and Methodology|August 2, 2021
COMBINING INFORMATION FROM MULTIPLE DATA SOURCES TO ASSESS POPULATION HEALTHTrivellore Raghunathan, Kaushik Ghosh, Allison Rosen, et al.
Health Services Research|March 19, 2026
National Trends in Market Competition for Hospital-Based Pediatric Services: 2011-2018Olivia Zhao, Carolyn San Soucie, Daniel A Rauch, et al.
Health Services Research|July 18, 2023
Specialist use among privately insured children with disabilitiesAlyna T Chien, Lauren E Wisk, Nancy Beaulieu, et al.
Critical Care Medicine|February 9, 2005
Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular responseAnand Kumar, Sergio Zanotti, Gene Bunnell, et al.
The American Journal of Managed Care|February 26, 2011
Bending the curve through health reform implementationJoseph Antos, John Bertko, Michael Chernew, et al.
Gastroenterology|April 6, 2007
SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonrespondersChristoph Sarrazin, Regine Rouzier, Frank Wagner, et al.
Pageof 9